Pharmacology of opioid analgesia: Clinical principles
作者： CARLA IDA RIPAMONTI , CLAUDIA BAREGGI
DOI: 10.1017/CBO9780511642357.012
关键词: Pharmacology 、 Opioid 、 Medicine 、 Anesthesia
摘要:
elsevier.com
sci-hub.se 参考文章(332)
Winston C.-V. Parris, Benjamin W. Johnson, Marilyn K. Croghan, Melvin R. Moore, Ali Khojasteh, Robert F. Reder, Robert F. Kaiko, Barbara J. Buckley, The use of controlled-release oxycodone for the treatment of chronic cancer pain: a randomized, double-blind study. Journal of Pain and Symptom Management. ,vol. 16, pp. 205- 211 ,(1998) , 10.1016/S0885-3924(98)00064-5
Bruno Gagnon, Abdulaziz Almahrezi, Gil Schreier, Methadone in the treatment of neuropathic pain Pain Research & Management. ,vol. 8, pp. 149- 154 ,(2003) , 10.1155/2003/236718
Nini Zaw-Tun, Eduardo Bruera, Active metabolites of morphine. Journal of Palliative Care. ,vol. 8, pp. 48- 50 ,(1992) , 10.1177/082585979200800212
Donna S Zhukovsky, Declan Walsh, Marie Doona, The relative potency between high dose oral oxycodone and intravenous morphine: a case illustration Journal of Pain and Symptom Management. ,vol. 18, pp. 53- 55 ,(1999) , 10.1016/S0885-3924(99)00024-X
Sulane Do Ouro, MD, Santiago Esteban, BS, Una Sibirceva, MD, Beverly Whittenberg, MD, Russell Portenoy, MD, Ricardo A. Cruciani, MD, PhD, Safety and tolerability of high doses of intrathecal fentanyl for the treatment of chronic pain. Journal of opioid management. ,vol. 2, pp. 365- 368 ,(2006) , 10.5055/JOM.2006.0053
Stephanie KA Blick, Antona J Wagstaff, None, Fentanyl buccal tablet: in breakthrough pain in opioid-tolerant patients with cancer. Drugs. ,vol. 66, pp. 2387- 2393 ,(2006) , 10.2165/00003495-200666180-00013
H H Hennies, J Schneider, E Friderichs, Receptor binding, analgesic and antitussive potency of tramadol and other selected opioids. Drug Research. ,vol. 38, pp. 877- 880 ,(1988)
Rosemarie Mannino, MD, Patrick Coyne, MSN, APRN, Craig Swainey, MD, Lea Ann Hansen, PharmD, Laurie Lyckholm, MD, Methadone for cancer-related neuropathic pain: A review of the literature Journal of opioid management. ,vol. 2, pp. 269- 276 ,(2006) , 10.5055/JOM.2006.0040
Lurcott G, The effects of the genetic absence and inhibition of CYP2D6 on the metabolism of codeine and its derivatives, hydrocodone and oxycodone. Anesthesia Progress. ,vol. 45, pp. 154- 156 ,(1998)
Carla Ripamonti, Eduardo Bruera, CNS Adverse Effects of Opioids in Cancer Patients CNS Drugs. ,vol. 8, pp. 21- 37 ,(1997) , 10.2165/00023210-199708010-00003